Strong antibody response after a first dose of a SARS-CoV-2 mRNA-based vaccine in kidney transplant recipients with a previous history of COVID-19
Open Access
- 30 December 2022
- journal article
- letter
- Published by Elsevier in American Journal of Transplantation
- Vol. 21 (11) , 3808-3810
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccineKidney International, 2021
- Weak anti–SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipientsKidney International, 2021
- Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant RecipientsJAMA, 2021
- Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals after mRNA vaccinationScience Immunology, 2021
- Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccineThe Lancet, 2021